Three Year Follow Up of the Randomized SCHEDULE Trial With Everolimus Initiation and Early Withdrawal of Calcineurin Inhibitor Therapy in De Novo Heart Transplant Recipients - A Multicenter, Randomized Scandinavian Trial

被引：1

作者：

Andreassen, A. K. ^{[1
]}

Andersson, B. ^{[2
]}

Gustafsson, F. ^{[3
]}

Eiskjaer, H. ^{[4
]}

Radegran, G. ^{[5
,6
]}

Gude, E. ^{[1
]}

Jansson, K. ^{[7
,8
]}

Solbu, D. ^{[9
]}

Karason, K. ^{[2
]}

Arora, S. ^{[1
]}

Dellgren, G. ^{[10
]}

Gullestad, I. ^{[1
]}

机构：

[1] Oslo Univ Hosp, Dept Cardiol, Oslo, Norway

[2] Sahlgrens Univ Hosp, Dept Cardiol, Gothenburg, Sweden

[3] Rigshosp, Dept Cardiol, DK-2100 Copenhagen, Denmark

[4] Aarhus Univ Hosp, Dept Cardiol, Skejby, Denmark

[5] Skane Univ Hosp, Dept Cardiol, Clin Heart Failure & Valvular Dis, Lund, Sweden

[6] Lund Univ, Lund, Sweden

[7] Cty Council Ostergotland, Dept Cardiol, Heart & Med Ctr, Linkoping, Sweden

[8] Linkoping Univ, Linkoping, Sweden

[9] Novartis Norge AS, Oslo, Norway

[10] Sahlgrens Univ Hosp, Transplant Inst, Gothenburg, Sweden

来源：

关键词：

D O I：

10.1016/j.healun.2015.01.346

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

332

引用

页码：S129 / S130

页数：2